BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 88.63 |
| Open | 89.46 |
| Bid | 89.42 x 100 |
| Ask | 89.55 x 300 |
| Day's Range | 88.89 - 89.81 |
| 52 Week Range | 76.02 - 99.56 |
| Volume | |
| Avg. Volume | 1,403,535 |
| Market Cap | 16.983B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 102.86 |
| EPS (TTM) | 0.87 |
| Earnings Date | Apr 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 109.74 |
ZacksGear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
ZacksEarnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.